U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H17NO3
Molecular Weight 211.2576
Optical Activity ( - )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVISOPRENALINE

SMILES

CC(C)NC[C@H](O)C1=CC=C(O)C(O)=C1

InChI

InChIKey=JWZZKOKVBUJMES-NSHDSACASA-N
InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3/t11-/m0/s1

HIDE SMILES / InChI
Molecular Formula C11H17NO3
Molecular Weight 211.2576
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:54:49 UTC 2023
Edited
by admin
on Fri Dec 15 15:54:49 UTC 2023
Record UNII
588N0603CT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEVISOPRENALINE
INN  
INN  
Official Name English
ISOPRENALINE, (R)-
Common Name English
levisoprenaline [INN]
Common Name English
ISOPROTERENOL L-FORM [MI]
Common Name English
ISOPROTERENOL, L-
Common Name English
(-)-(R)-.ALPHA.-(ISOPROPYLAMINOMETHYL)PROTOCATECHUYL ALCOHOL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C319
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
NCI_THESAURUS C48149
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
Code System Code Type Description
EVMPD
SUB08460MIG
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
CAS
51-31-0
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
SMS_ID
100000082804
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
NCI_THESAURUS
C74197
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
INN
864
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
DRUG CENTRAL
2388
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
PUBCHEM
443372
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
CHEBI
6257
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
FDA UNII
588N0603CT
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
ChEMBL
CHEMBL460574
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
EPA CompTox
DTXSID2043878
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY
MERCK INDEX
m6533
Created by admin on Fri Dec 15 15:54:49 UTC 2023 , Edited by admin on Fri Dec 15 15:54:49 UTC 2023
PRIMARY Merck Index
Related Record Type Details
BETA-1 ADRENERGIC RECEPTOR
TARGET -> AGONIST
Mouse receptor value
Ki
BETA-2 ADRENERGIC RECEPTOR
TARGET -> AGONIST
Kact cAMP effects in CHO cells expressing human beta-2 receptor.
EC50
CATECHOL O-METHYLTRANSFERASE
METABOLIC ENZYME -> SUBSTRATE
BETA-1 ADRENERGIC RECEPTOR
TARGET -> AGONIST
Kact cAMP effects Kact cAMP effects in CHO cells expressing human beta-1 receptor.
EC50
Structure of LEVISOPRENALINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
BETA-2 ADRENERGIC RECEPTOR
TARGET -> AGONIST
Ki
BETA-3 ADRENERGIC RECEPTOR
TARGET -> AGONIST
EC50
Related Record Type Details
Structure of LEVISOPRENALINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966